Related references
Note: Only part of the references are listed.Biologics for Inflammatory Bowel Disease and Their Safety Pregnancy: A Systematic Review and Meta-analysis
Ole Haagen Nielsen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease
Uma Mahadevan et al.
GASTROENTEROLOGY (2021)
Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study
Pauline Wils et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study
Annick Moens et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Systematic review with meta-analysis: risk of adverse pregnancy-related outcomes in inflammatory bowel disease
Parul Tandon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure
Emma Flanagan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
S0842 The Vedolizumab Pregnancy Exposure Registry: An OTIS Pregnancy Study Update
Christina D. Chambers et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab
Marco Galluzzo et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2019)
Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study
Maria C. Magnus et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
P014 The safety profile of vedolizumab in ulcerative colitis and Crohnʼs disease
Cohen Russell D. et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Exposure to Vedolizumab in IBD Pregnant Women Appears of Low Risk for Mother and Neonate: A First Prospective Comparison Study
Ariella Bar-Gil Shitrit et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Letter: vedolizumab drug concentrations in neonates following intrauterine exposure
Emma Flanagan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Indications for Mode of Delivery in Pregnant Women with Inflammatory Bowel Disease
Kristin E. Burke et al.
INFLAMMATORY BOWEL DISEASES (2017)
The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease
Heidi Kammerlander et al.
INFLAMMATORY BOWEL DISEASES (2017)
Preterm birth: Inflammation, fetal injury and treatment strategies
Ashley K. Boyle et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2017)
Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease
U. Mahadevan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
Geoffrey C. Nguyen et al.
GASTROENTEROLOGY (2016)
Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment
Gabriella Broms et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes
Heather A. Boyd et al.
PLOS ONE (2015)
Anti-TNFα Therapies Are Safe During Pregnancy in Women with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Neeraj Narula et al.
INFLAMMATORY BOWEL DISEASES (2014)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Exclusive antagonism of the α4β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates
Eric R. Fedyk et al.
INFLAMMATORY BOWEL DISEASES (2012)
Inflammatory bowel disease and pregnancy: overlapping pathways
Noha Ahmed Nasef et al.
TRANSLATIONAL RESEARCH (2012)
Crohn's Disease Is a Risk Factor for Preterm Birth
Olof Stephansson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Relationships Between Inflammatory Bowel Disease and Perinatal Factors: Both Maternal and Paternal Disease Are Related to Preterm Birth of Offspring
May-Bente Bengtson et al.
INFLAMMATORY BOWEL DISEASES (2010)
Outcomes of Obstetric Hospitalizations Among Women With Inflammatory Bowel Disease in the United States
Geoffrey C. Nguyen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-alpha(4)beta(7) Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
Dulce Soler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence
Mostafa Metwally et al.
FERTILITY AND STERILITY (2008)
Pregnancy outcomes in women with inflammatory bowel disease: A large community-based study from Northern California
Uma Mahadevan et al.
GASTROENTEROLOGY (2007)
A meta-analysis on the influence of inflammatory bowel disease on pregnancy
J. Cornish et al.
GUT (2007)
Functional involvement of P-selectin and MAdCAM-1 in the recruitment of α4β7-integrin-expressing monocyte-like cells to the pregnant mouse uterus
U Fernekorn et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Share Paper
